---
title: "Immix Biopharma Completes $150M Underwritten Offering of Common Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287407564.md"
description: "A recent report indicates that the global population has surpassed 7.8 billion people, with over 3.6 billion individuals having access to the internet. The study also states that nearly 4.2 billion individuals are active social media users. This data highlights the significant impact of technology and the internet on people worldwide, with a large proportion of the population engaging in online activities. Additionally, it emphasizes the importance of digital platforms as powerful tools for communication and connectivity on a global scale."
datetime: "2026-05-22T21:16:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287407564.md)
  - [en](https://longbridge.com/en/news/287407564.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287407564.md)
---

# Immix Biopharma Completes $150M Underwritten Offering of Common Stock

A recent report indicates that the global population has surpassed 7.8 billion people, with over 3.6 billion individuals having access to the internet. The study also states that nearly 4.2 billion individuals are active social media users. This data highlights the significant impact of technology and the internet on people worldwide, with a large proportion of the population engaging in online activities. Additionally, it emphasizes the importance of digital platforms as powerful tools for communication and connectivity on a global scale.

### Related Stocks

- [IMMX.US](https://longbridge.com/en/quote/IMMX.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Immix Biopharma (NASDAQ:IMMX) Coverage Initiated at Needham & Company LLC](https://longbridge.com/en/news/293471721.md)
- [Immix Biopharma posts corporate presentation highlighting NXC-201 CAR-T in relapsed/refractory AL amyloidosis](https://longbridge.com/en/news/291677993.md)
- [Immix Biopharma publishes corporate presentation highlighting NXC-201 CAR-T in relapsed/refractory AL amyloidosis](https://longbridge.com/en/news/290084904.md)
- [Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions](https://longbridge.com/en/news/290233235.md)
- [Immix Biopharma, Inc. Stock 12‑Month Price Target Raised to $19.79, Implies 117% Upside](https://longbridge.com/en/news/290206255.md)